Back to dashboard
MedicaidAdministrativeLow impact

Newsletter Vol. 11, No. 40

New Jersey Medicaid·NJ·Pharmacy
Effective date
Mar 14, 2001
We identified it
Jun 20, 2026
Days to comply

Summary

New Jersey added DrugAbuse Sciences (Labeler Code 65694) to the PAAD Drug Rebate Program effective March 14, 2001. This addition allows pharmaceutical providers to process rebates for this manufacturer's products under the New Jersey PAAD program.

Action Required

Action needed
No action required for billing teams outside New Jersey or not participating in the New Jersey PAAD program. New Jersey pharmacy providers should retain this newsletter behind the blue tab marked '5' and be aware that DrugAbuse Sciences products are now eligible for PAAD rebates.